Skip to main content

Closed

LEXX: Lexaria Bioscience Corp. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+52.0% / yr

Operating margin-3973.2%

ROIC-174.0%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio10.60×

Lexaria Bioscience Corp.

LEXXNASDAQ Capital Market·USD·Closed

Lexaria Bioscience Corp.

LEXXNASDAQ·USD·Closed

$0.39

−1.34%

$0.39

−$0.01 (1.34%)

52W Range

3thpctl

Volume

5.28×avg

Mkt Cap

9.69MUSD

P/E

-1.1TTM

Div Yield

–ann

52W Range

3thpctl

Volume

5.28×avg

Market Cap

9.69MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings